Lansoprazole enteric-coated tablets

A new type of drug that inhibits gastric acid secretion. It acts on the H-K-ATPase of gastric parietal cells, preventing the H of parietal cells from being transported to the stomach, resulting in a significant reduction in the amount of gastric acid in gastric juice. It is clinically used for the treatment of duodenal ulcer, gastric ulcer, reflux esophagitis, and Zollinger-Ellison syndrome (gastrinoma), with significant efficacy, and has an inhibitory effect on Helicobacter pylori.

The main ingredient of this product is lansoprazole. Its chemical name is 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]-sulfinyl]-1H-benzimidazole.

This product is a white enteric-coated tablet, which appears white or off-white after removing the enteric coating.

Gastric ulcer, duodenal ulcer, reflux esophagitis, Zollinger-Ellison syndrome (gastrinoma).

For the treatment of gastric ulcer and duodenal ulcer, take orally once a day in the early morning, 15-30 mg each time, or as directed by a doctor.

The side effects are mild, mainly manifested as dry mouth, dizziness, and nausea.

Pregnant or lactating women should not use it.

Precautions for children: The safety of the drug for children has not been established (there is very little clinical experience in children). Precautions for pregnancy and lactation: Pregnant and lactating women should not use. Precautions for the elderly: Generally speaking, the gastric acid secretion capacity and other physiological functions of elderly patients will be reduced, so please pay attention during medication.

Not yet clear.

Keep away from light, seal tightly, and store in a cool, dark and dry place.

15mg

24 months.

Shantou Special Economic Zone Tuobin Pharmaceutical Factory

• Founded in:

  1990-04-28

• Address:

  3rd Floor, Building 1, No. 48, Pujiang Road, Longhu District, Shantou City

• Tax NO.:

  91440507192779142H

• Registered Funds:

  34.26 million yuan

• Website:

  Log in to view

• Email:

  Log in to view